Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K. Cunningham, Karin Nielsen‐Saines, Charlotte Perlowski et al.|The Journal of Infectious Diseases|2019Cited by 62
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cellsJolien M.R. Van der Meer, Harry Dolstra, Ralph J. A. Maas et al.|Cancer Immunology Immunotherapy|2020Cited by 48
HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV TransmissionYegor Voronin, W. F. Snow, Lynne Mofenson et al.|PLoS Medicine|2014Cited by 34
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cellsJolien M.R. Van der Meer, Harry Dolstra, Ralph J. A. Maas et al.|Cancer Immunology Immunotherapy|2021Cited by 2